RICTOR (a component of the mTORC2 complex) expression is altered in several cancer types, and its involvement in cancer progression is likely explained by its well-known role in AKT signaling [reviewed in Gkountakos et al. (2018)]. This evidence concerns the gene RICTOR and cancer.